40 results on '"Dallan LAO"'
Search Results
2. Predictors of 30-Day Hospital Readmission Following CABG in a Multicenter Database: A Cross-Sectional Study.
- Author
-
Silva RAGE, Borgomoni GB, de Freitas FL, Maia ADS, Farias do Vale Junior C, Pereira EDS, Silvestre LGI, Dallan LRP, Lisboa LA, Dallan LAO, Jatene FB, and Mejia OAV
- Subjects
- Humans, Cross-Sectional Studies, Female, Male, Middle Aged, Aged, Risk Factors, Retrospective Studies, Time Factors, Databases, Factual, Logistic Models, Patient Readmission statistics & numerical data, Coronary Artery Bypass adverse effects, Coronary Artery Bypass statistics & numerical data, Postoperative Complications
- Abstract
Background: The analysis of indicators such as hospital readmission rates is crucial for improving the quality of services and management of hospital processes., Objectives: To identify the variables correlated with hospital readmission up to 30 days following coronary artery bypass grafting (CABG)., Methods: Cross-sectional cohort study by REPLICCAR II database (N=3,392) from June 2017 to June 2019. Retrospectively, 150 patients were analyzed to identify factors associated with hospital readmission within 30 days post-CABG using univariate and multivariate logistic regression. Analysis was conducted using software R, with a significance level of 0.05 and 95% confidence intervals., Results: Out of 3,392 patients, 150 (4,42%0 were readmitted within 30 days post-discharge from CABG primarily due to infections (mediastinitis, surgical wounds, and sepsis) accounting for 52 cases (34.66%). Other causes included surgical complications (14/150, 9.33%) and pneumonia (13/150, 8.66%). The multivariate regression model identified an intercept (OR: 1.098, p<0.00001), sleep apnea (OR: 1.117, p=0.0165), cardiac arrhythmia (OR: 1.040, p=0.0712), and intra-aortic balloon pump use (OR: 1.068, p=0.0021) as predictors of the outcome, with an AUC of 0.70., Conclusion: 4.42% of patients were readmitted post-CABG, mainly due to infections. Factors such as sleep apnea (OR: 1.117, p=0.0165), cardiac arrhythmia (OR: 1.040, p=0.0712), and intra-aortic balloon pump use (OR: 1.068, p=0.0021) were predictors of readmission, with moderate risk discrimination (AUC: 0.70).
- Published
- 2024
- Full Text
- View/download PDF
3. Age, Renal Failure and Transfusion are Risk Predictors of Prolonged Hospital Stay after Coronary Artery Bypass Grafting Surgery.
- Author
-
Andrade DPG, Freitas FL, Borgomoni GB, Goncharov M, Silva PGMBE, Nakazone MA, Campagnucci VP, Tiveron MG, Lisboa LA, Dallan LAO, Jatene FB, and Mejia OAV
- Subjects
- Humans, Female, Male, Middle Aged, Aged, Risk Factors, Cross-Sectional Studies, Age Factors, Brazil epidemiology, Blood Transfusion statistics & numerical data, Risk Assessment, Prospective Studies, Coronary Artery Bypass statistics & numerical data, Coronary Artery Bypass adverse effects, Length of Stay statistics & numerical data, Renal Insufficiency
- Abstract
Background: Identifying risk factors in cardiovascular surgery assists in predictability, resulting in optimization of outcomes and cost reduction., Objective: This study aimed to identify preoperative and intraoperative risk predictors for prolonged hospitalization after coronary artery bypass grafting (CABG) surgery in the state of São Paulo, Brazil., Methods: A cross-sectional analysis using data from the REPLICCAR II database, a prospective, consecutive, multicenter registry that included CABG surgeries performed between August 2017 and July 2019. The primary outcome was a prolonged hospital stay (PHS), defined as a postoperative period exceeding 14 days. Univariate and multivariate logistic regression analyses were performed to identify the predictors with significance set at p <0.05., Results: The median age was 63 (57-70) years and 26.55% of patients were female. Among the 3703 patients analyzed, 228 (6.16%) had a PHS after CABG, with a median hospital stay of 17 (16-20) days. Predictors of PHS after CABG included age >60 years (OR 2.05; 95% CI 1.43-2.87; p<0.001); renal failure (OR 1.73; 95% CI 1.29-2.32; p <0.001) and intraoperative red blood cell transfusion (OR 1.32; 95% CI 1.07-2.06; p=0.01)., Conclusion: Age >60 years, renal failure, and intraoperative red blood cell transfusion were independent predictors of PHS after CABG. The identification of these variables can help in multiprofessional strategic planning aimed to enhance results and resource utilization in the state of São Paulo.
- Published
- 2024
- Full Text
- View/download PDF
4. Markers of Tissue Perfusion as Predictors of Adverse Outcomes in Patients with Left Ventricular Dysfunction Undergoing Coronary Artery Bypass Surgery.
- Author
-
Yamaguti T, Auler Junior JOC, Dallan LAO, Galas FRBG, Cunha LCC, and Piccioni MA
- Subjects
- Humans, Perfusion, Biomarkers, Lactates, Coronary Artery Bypass adverse effects, Ventricular Dysfunction, Left etiology
- Abstract
Background: Cardiac surgery patients may be exposed to tissue hypoperfusion and anaerobic metabolism., Objective: To verify whether the biomarkers of tissue hypoperfusion have predictive value for prolonged intensive care unit (ICU) stay in patients with left ventricular dysfunction who underwent coronary artery bypass surgery., Methods: After approval by the institution's Ethics Committee and the signing of informed consent, 87 patients with left ventricular dysfunction (ejection fraction < 50%) undergoing coronary artery bypass surgery were enrolled. Hemodynamic and metabolic biomarkers were collected at five time points: after anesthesia, at the end of the surgery, at ICU admission, and at six and twelve hours after. An analysis of variance for repeated measures followed by a Bonferroni post hoc test was used for repeated, continuous variables (hemodynamic and metabolic variables) to determine differences between the two groups over the course of the study period. The level of statistical significance adopted was 5%., Results: Thirty-eight patients (43.7%) who presented adverse outcomes were older, higher Euro score (p<0.001), and elevated ΔpCO2 as analyzed 12 hours after ICU admission (p<0.01), while increased arterial lactate concentration at 6 hours postoperatively was found to be a negative predictive factor (p<0.01)., Conclusions: Euro SCORE, six-hour postoperative arterial lactate, 12-hour postoperative ΔPCO2, and eRQ are independent predictors of adverse outcomes in patients with left ventricular dysfunction after cardiac surgery.
- Published
- 2024
- Full Text
- View/download PDF
5. Immediate Results after Multiple Arterial Grafts in Coronary Artery Bypass Graft Surgery in the São Paulo State: Cross Cohort Study.
- Author
-
Paredes RAM, Borgomoni GB, Micalay AKP, Camacho JCA, Dallan LRP, Lisboa LAF, Dallan LAO, and Mejia OAV
- Subjects
- Male, Humans, Female, Cohort Studies, Glycated Hemoglobin, Cross-Sectional Studies, Retrospective Studies, Risk Factors, Treatment Outcome, Brazil epidemiology, Coronary Artery Bypass adverse effects, Coronary Artery Bypass methods, Mammary Arteries, Coronary Artery Disease
- Abstract
Background: The short-term results after using arterial grafts still raise questions and doubts for medical society., Objective: To compare the immediate outcomes of patients undergoing single arterial graft versus multiple arterial grafts coronary artery bypass grafting surgery., Methods: Cross-sectional cohort study in the São Paulo Registry of Cardiovascular Surgery II (REPLICCAR II). Perioperative data from 3122 patients were grouped by the number of arterial grafts used, and their outcomes were compared: reoperation, deep sternal wound infection (DSWI), stroke, acute kidney injury, prolonged intubation (>24 hours), short hospital stay (<6 days), prolonged hospital stay (>14 days), morbidity and mortality. Propensity Score Matching (PSM) matched 1062 patients, adjusted for the mortality risk., Results: After PSM, the single arterial graft group showed patients with advanced age, more former smokers, hypertension, diabetes, stable angina, and previous myocardial infarction. In the multiple arterial grafts, there was a predominance of males, recent pneumonia, and urgent surgeries. After the procedure, there was a higher incidence of pleural effusion (p=0.042), pneumonia (p=0.01), reintubation (p=0.006), DSWI (p=0.007), and sternal debridement (p=0.015) in the multiple arterial grafts group, however, less need for blood transfusion (p=0.005), extremity infections (p=0.002) and shorter hospital stays (p=0.036). Bilateral use of the internal thoracic artery was not related to increased DSWI rate, but glycosylated hemoglobin >6.40% (p=0.048)., Conclusion: Patients undergoing the multiarterial technique had a higher incidence of pulmonary complications, and DSWI, where glycosylated hemoglobin ≥6.40%, had a greater influence on the infectious outcome than the choice of grafts.
- Published
- 2023
- Full Text
- View/download PDF
6. Additional improvement in regional myocardial ischemia after intracardiac injection of bone marrow cells during CABG surgery.
- Author
-
Gowdak LHW, Schettert IT, Rochitte CE, de Carvalho LP, Vieira MLC, Dallan LAO, de Oliveira SA, César LAM, Brito JOR, Guarita-Souza LC, de Carvalho ACC, and Krieger JE
- Abstract
Background: Post-procedure residual ischemia is associated with worse prognosis in patients with coronary artery diasease (CAD)., Objective: We evaluated whether autologous bone marrow-derived cells (BMC) contribute to additional reduction in regional stress-induced myocardial ischemia (SIMI) in patients undergoing incomplete coronary artery bypass graft surgery (CABG)., Methods: In a double-blind, randomized, placebo-controlled trial, we enrolled 143 patients (82% men, 58 ± 11 years) with stable CAD and not candidates for complete CABG. They received 100 million BMC ( n = 77) or placebo ( n = 66) injected into ischemic non-revascularized segments during CABG. The primary outcome was improvement on SIMI quantified as the area at risk in injected segments assessed by cardiovascular magnetic resonance (CMR) 1, 6, and 12 months after CABG., Results: The reduction in global SIMI after CABG was comparable ( p = 0.491) in both groups indicating sustained beneficial effects of the surgical procedure over 12 month period. In contrast, we observed additional improvement in regional SIMI in BMC treated group ( p = 0.047). Baseline regional SIMI values were comparable [18.5 (16.2-21.0) vs. 18.5 (16.5-20.7)] and reached the lowest values at 1 month [9.74 (8.25; 11.49) vs. 12.69 (10.84; 14.85)] for BMC and placebo groups, respectively. The ischemia's improvement from baseline represented a 50% difference in regional SIMI in favor of the BMC transplanted group at 30 days. We found no differences in clinical and LVEF% between groups during the 12 month follow-up period. The 1 month rate of major adverse cerebral and cardiovascular events (MACCE) ( p = 0.34) and all-cause mortality ( p = 0.08) did not differ between groups 1 month post intervention., Conclusion: We provided evidence that BMC leads to additional reduction in regional SIMI in chronic ischemic patients when injected in segments not subjected to direct surgical revascularization. This adjuvant therapy deserves further assessment in patients with advanced CAD especially in those with microcirculation dysfunction., Clinical Trial Registration: https://clinicaltrials.gov/, identifier NCT01727063., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Gowdak, Schettert, Rochitte, de Carvalho, Vieira, Dallan, de Oliveira, César, Brito, Guarita-Souza, de Carvalho and Krieger.)
- Published
- 2023
- Full Text
- View/download PDF
7. Transit-time flow measurement parameters after protamine infusion in CABG surgeries.
- Author
-
Dallan LRP, Dallan LAO, Lisboa LAF, Mejia OAV, Platania F, Rodrigues RC, Dallan LAP, and Jatene FB
- Subjects
- Blood Flow Velocity, Coronary Circulation physiology, Humans, Protamines, Vascular Patency, Coronary Artery Bypass methods, Mammary Arteries transplantation
- Abstract
Objective: The objective of this study is to evaluate protamine sulfate effects on graft's blood flow by comparing transit-time flow measurement (TTFM) values before and after protamine administration., Methods: This is an observational study with data collected between years 2018 and 2020. Immediate graft patency was evaluated using TTFM. Only patients with TTFM parameters registered before and after protamine infusion were included. The main three parameters studied were: mean graft flow (MGF), pulsatility index (PI), and diastolic flow (DF). In the first analysis, all conduits were evaluated regardless of the surgical technique used. In a second analysis, on-pump and off-pump groups were compared. Evaluated grafts were left internal thoracic artery, saphenous vein graft (SVG), radial artery, and right internal thoracic artery. Since SVG was numerically the most used graft, an exclusive analysis was created., Results: Our study included 575 patients, resulting in a total of 1686 grafts, mean 2.93 grafts/patient. Off-pump surgery was performed in 158 patients. Before protamine infusion, inadequate TTFM parameters were observed in 3.8% of grafts. Overall, after protamine administration, MGF decreased in all grafts, but its reduction was not statistically significant. PI values increased in the SVG and DF values reduced in LIMA grafts. SVG group analysis showed that after protamine PI values were higher in OM1 and RCA. DF values increased in RCA. The comparison between off and on-pump surgeries, showed that in off-pump cases TTFM measures did not present statistically significant differences., Conclusion: Significant variations were observed in TTFM values before and after protamine administration. Although different, those values remained within the normal reference ranges. We recommend that flow measurement should be performed before protamine infusion., (© 2022 Wiley Periodicals LLC.)
- Published
- 2022
- Full Text
- View/download PDF
8. A benchmark in the isolated tricuspid valve surgery is necessary.
- Author
-
Dallan LAO, Ferreira Lisboa LA, Dallan LRP, and Jatene FB
- Subjects
- Benchmarking, Humans, Treatment Outcome, Tricuspid Valve surgery, Cardiac Surgical Procedures, Heart Valve Prosthesis Implantation methods, Tricuspid Valve Insufficiency surgery
- Abstract
Advances in surgical techniques, enabling correction of regurgitation, and preserving the tricuspid valve, are also factors that encourage early surgical indication and improve long-term outcomes., (© 2022 Wiley Periodicals LLC.)
- Published
- 2022
- Full Text
- View/download PDF
9. Adherence to the cardiac surgery checklist decreased mortality at a teaching hospital: A retrospective cohort study.
- Author
-
Mejia OAV, de Mendonça FCC, Sampaio LABN, Galas FRBG, Pontes MF, Caneo LF, Dallan LRP, Lisboa LAF, Ferreira JFM, Dallan LAO, and Jatene FB
- Subjects
- Cross-Sectional Studies, Hospital Mortality, Hospitals, Teaching, Humans, Retrospective Studies, Cardiac Surgical Procedures adverse effects, Checklist
- Abstract
Objective: To evaluate the impact of adherence to the cardiac surgical checklist on mortality at the teaching hospital., Methods: A retrospective cohort study after the implementation of the cardiac surgical safety checklist in a reference hospital in Latin America. All patients undergoing coronary artery bypass surgery and/or heart valve surgery from 2013 to 2019 were analyzed. After the implementation of the project InCor-Checklist "Five steps to safe cardiac surgery" in 2015, the correlation between adherence and completeness of this instrument with surgical mortality was assessed. The EuroSCORE II was used as a reference to assess the risk of expected mortality for patients. Cross-sectional questionnaires were during the implementation of the InCor-Checklist. To perform the correlation, Pearson's coefficient was calculated using R software., Results: Since 2013, data from 8139 patients have been analyzed. The average annual mortality was 5.98%. In 2015, the instrument was used in only 58% of patients; in contrast, it was used in 100% of patients in 2019. There was a decrease in surgical mortality from 8.22% to 3.13% for the same group of procedures. The results indicate that the greater the checklist use, the lower the surgical mortality (r = 88.9%). In addition, the greater the InCor-Checklist completeness, the lower the surgical mortality (r = 94.1%)., Conclusion: In the formation of the surgical patient safety culture, the implementation and adherence to the InCor-Checklist "Five steps to safe cardiac surgery" was associated with decreased mortality after cardiac surgery., Competing Interests: Conflicts of interest The authors declare no conflicts of interest., (Copyright © 2022 HCFMUSP. Published by Elsevier España, S.L.U. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
10. Endovascular therapeutic hypothermia adjunctive to percutaneous coronary intervention in acute myocardial infarction: realistic simulation as a game changer.
- Author
-
Dallan LAP, Dae M, Giannetti NS, Polastri TF, Lima MKF, Rochitte CE, Hajjar LA, San Martin CYB, Lima FG, Nicolau JC, de Oliveira MT Jr, Dallan LAO, Ribeiro da Silva EE, Kalil Filho R, Abizaid A, Lemos Neto PA, and Timerman S
- Subjects
- Humans, Time Factors, Treatment Outcome, Hypothermia, Induced adverse effects, Myocardial Infarction diagnosis, Myocardial Infarction therapy, Percutaneous Coronary Intervention adverse effects, Percutaneous Coronary Intervention methods, ST Elevation Myocardial Infarction diagnosis, ST Elevation Myocardial Infarction therapy
- Abstract
Background: Endovascular therapeutic hypothermia (ETH) reduces the damage by ischemia/reperfusion cell syndrome in cardiac arrest and has been studied as an adjuvant therapy to percutaneous coronary intervention (PCI) in ST-elevation myocardial infarction (STEMI). New available advanced technology allows cooling much faster, but there is paucity of resources for training to avoid delays in door-to-balloon time (DTB) due to ETH and subsequently coronary reperfusion, which would derail the procedure. The aim of the study was to describe the process for the development of a simulation, training & educational protocol for the multidisciplinary team to perform optimized ETH as an adjunctive therapy for STEMI., Methods and Results: We developed an optimized simulation protocol using modern mannequins in different realistic scenarios for the treatment of patients undergoing ETH adjunctive to PCI for STEMIs starting from the emergency room, through the CathLab, and to the intensive care unit (ICU) using the Proteus® Endovascular System (Zoll Circulation Inc™, San Jose, CA, USA). The primary endpoint was door-to-balloon (DTB) time. We successfully trained 361 multidisciplinary professionals in realistic simulation using modern mannequins and sham situations in divisions of the hospital where real patients would be treated. The focus of simulation and training was logistical optimization and educational debriefing with strategies to reduce waste of time in patient's transportation from different departments, and avoiding excessive rewarming during transfer. Afterwards, the EHT protocol was successfully validated in a trial randomizing 50 patients for 18 minutes cooling before coronary recanalization at the target temperature of 32 ± 1.0 ∘C or PCI-only. A total of 35 patients underwent ETH (85.7% [30/35] in 90 ± 15 minutes), without delays in the mean door-to-balloon time for primary PCI when compared to 15 control group patients (92.1 minutes versus 87 minutes, respectively; p = 0.509)., Conclusions: Realistic simulation, intensive training and educational debriefing for the multidisciplinary team propitiated feasible endovascular therapeutic hypothermia as an adjuvant therapy to primary PCI in STEMI., Clinicaltrials: gov: NCT02664194., Competing Interests: Michael Dae is a consultant for ZOLL Circulation Inc (San Jose, CA, USA). None of the other authors have conflicts of interest related to this article., (© 2022 The Author(s). Published by IMR Press.)
- Published
- 2022
- Full Text
- View/download PDF
11. Impact of the First Wave of the COVID-19 Pandemic on Cardiovascular Surgery in Brazil: Analysis of a Tertiary Reference Center.
- Author
-
Lisboa LA, Mejia OAV, Arita ET, Guerreiro GP, Silveira LMVD, Brandão CMA, Dias RR, Dallan LRP, Miana L, Caneo LF, Jatene MB, Dallan LAO, and Jatene FB
- Subjects
- Brazil epidemiology, Humans, COVID-19, Pandemics prevention & control
- Published
- 2022
- Full Text
- View/download PDF
12. Multivessel Woven Coronary Artery Disease.
- Author
-
Dallan LRP, Dallan LAO, Moretti M, Moragas ABC, Dallan LAP, and B Jatene F
- Subjects
- Coronary Artery Bypass, Humans, Treatment Outcome, Coronary Artery Disease diagnostic imaging, Coronary Artery Disease surgery
- Abstract
Woven coronary disease is a rare pathology with unknown etiology. Although initially considered benign, recent publications report myocardial ischemia caused by the affected vessel. Since most patients are asymptomatic, long-term follow-up to understand its behavior is mandatory. We report a multivessel woven disease case with documented ischemia that was submitted to coronary artery bypass grafting and remained asymptomatic for two years of follow-up.
- Published
- 2021
- Full Text
- View/download PDF
13. Correction: Mortality risk prediction in high-risk patients undergoing coronary artery bypass grafting: Are traditional risk scores accurate?
- Author
-
Goncharov M, Mejia OAV, Perez de Souza Arthur C, Orlandi BMM, Sousa A, Praça Oliveira MA, Atik FA, Segalote RC, Tiveron MG, de Barros E Silva PGM, Nakazone MA, Lisboa LAF, Dallan LAO, Zheng Z, Hu S, and Jatene FB
- Abstract
[This corrects the article DOI: 10.1371/journal.pone.0255662.].
- Published
- 2021
- Full Text
- View/download PDF
14. The Role of the Heart Team in Patients with Diffuse Coronary Artery Disease Undergoing Coronary Artery Bypass Grafting.
- Author
-
Dourado LOC, Pereira AC, Poppi NT, Cavalcante R, Gaiotto F, Dallan LAO, Bittencourt MS, Cesar LAM, and Gowdak LHW
- Subjects
- Coronary Angiography, Coronary Artery Bypass adverse effects, Humans, Retrospective Studies, Treatment Outcome, Coronary Artery Disease diagnostic imaging, Coronary Artery Disease surgery
- Abstract
Background: In patients eligible for coronary artery bypass grafting, no data assess the importance of the Heart Team in programming the best surgical strategy for patients with diffuse coronary artery disease (CAD). This study aims to determine the contribution of the Heart Team in predicting the feasibility of coronary artery bypass graft and angiographic surgical success in these patients based on visual angiographic analysis., Methods: Patients with diffuse and severe CAD undergoing incomplete coronary artery bypass graft surgery were prospectively included. One-year postoperative coronary angiograms were obtained to evaluate graft occlusion. Two clinical cardiologists, two cardiovascular surgeons, and one interventional cardiologist retrospectively analyzed preoperative angiograms. A subjective scale was applied at a single moment to quantify the chance of successful coronary artery bypass grafting for each coronary territory with anatomical indication for revascularization. Based on individual scores, the Heart Team's and the specialists' scores were calculated and compared., Results: The examiners evaluated 154 coronary territories, of which 85 (55.2%) were protected. The Heart Team's accuracy for predicting the angiographic success of the surgery was 74.9%, almost equal to that of the surgeons alone (73.2%). Only the interventional cardiologist predicted left anterior descending territory grafting success. The Heart Team had good specificity and reasonable sensitivity, and the surgeons had high sensitivity and low specificity in predicting angiographic success., Conclusion: The multispecialty Heart Team achieved good accuracy in predicting the angiographic coronary artery bypass graft success in patients with diffuse CAD, with a high specificity and reasonable sensitivity., Competing Interests: None declared., (Thieme. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
15. The arrival of COVID-19 in Brazil and the impact on coronary artery bypass surgery.
- Author
-
Mejia OAV, Borgomoni GB, Silveira LMV, Guerreiro GP, Falcão Filho ATG, Goncharov M, Dallan LRP, Oliveira MAP, de Sousa AG, Nakazone MA, Tiveron MG, Campagnucci VP, de Barros E Silva PGM, Dallan LAO, Lisboa LAF, and Jatene FB
- Subjects
- Brazil, Coronary Artery Bypass, Humans, Retrospective Studies, Risk Assessment, Risk Factors, SARS-CoV-2, COVID-19, Pandemics
- Abstract
Background and Aim of the Study: This study analyzed the arrival of coronavirus disease 2019 (COVID-19) in Brazil and its impact on coronary artery bypass grafting (CABG) surgery., Methods: Patients undergoing isolated CABG in six hospitals in Brazil were divided into two periods: pre-COVID-19 (March-May 2019, N = 468) and COVID-19 era (March-May 2020, N = 182). Perioperative data were included on a dedicated REDCap platform. Patients with clinical and tomographic criteria and/or PCR (+) for severe acute respiratory syndrome coronavirus 2 infection were considered COVID-19 (+). Logistic regression analysis was performed to create a multiple predictive model for mortality after CABG in COVID-19 era., Results: Compared to 2019, in 2020, CABG surgeries had a 2.8-fold increased mortality risk (95% confidence interval [CI]: 1-7.6, p = .041), patients who evolved with COVID-19 had a 11-fold increased mortality risk (95% CI: 2.2-54.9, p < .003), rates of morbidities and readmission to the intensive care unit. The surgical volume was decreased by 60%. The model to predict mortality after CABG in the COVID-19 era was validated with good calibration (Hosmer-Lemeshow = 1.43) and discrimination (receiver operating characteristic = 0.78)., Conclusion: The COVID-19 pandemic had an adverse impact on mortality, morbidity and volume of patients undergoing CABG., (© 2021 Wiley Periodicals LLC.)
- Published
- 2021
- Full Text
- View/download PDF
16. Impact of COVID-19 on coronary artery surgery: Hard lessons learned.
- Author
-
Dallan LAO, F Lisboa LA, Dallan LRP, and Jatene FB
- Subjects
- Coronary Artery Bypass, Humans, SARS-CoV-2, Vascular Surgical Procedures, COVID-19, Cardiac Surgical Procedures
- Published
- 2021
- Full Text
- View/download PDF
17. Pericardial-Peritoneal Window as an Alternative Treatment for Large and Recurrent Pericardial Effusion Post-Pericardiotomy.
- Author
-
Dallan LRP, Dallan LAO, Mejía OV, Dallan LAP, Lisboa LAF, and Jatene FB
- Subjects
- Female, Humans, Pericardial Window Techniques, Pericardiectomy, Cardiac Surgical Procedures adverse effects, Cardiac Tamponade etiology, Cardiac Tamponade surgery, Pericardial Effusion diagnostic imaging, Pericardial Effusion etiology, Pericardial Effusion surgery
- Abstract
Introduction: The presence of mild to moderate pericardial effusion after cardiac surgery is common and oral medical therapy is usually able to treat it. Larger effusions are less frequent and surgical intervention is usually necessary. However, there are some rare cases of large effusions that are recurrent even after intervention and become challenging to treat., Methods: We describe the case of a patient submitted to coronary artery bypass grafting (CABG) without any intraoperative complications, who was regularly discharged from the hospital. She was referred to our emergency department twice after surgery with large pericardial effusion that was drained. Even after those two interventions and with adequate oral medication, the large effusion recurred., Results: During follow-up, the patient had her symptoms resolved, with no need for further hospital admission. Her echocardiograms after the last intervention showed no pericardial effusion. The present surgical technique demonstrated to be easy to perform, thus it should be considered as a treatment option for these rare cases of large and repetitive effusions, which do not respond to the traditional methods., Conclusions: In challenging cases of recurrent and large pericardial effusions, the pericardial-peritoneal window is an alternative surgical technique that brings clinical improvement and diminishes the risk of cardiac tamponade.
- Published
- 2021
- Full Text
- View/download PDF
18. Mortality risk prediction in high-risk patients undergoing coronary artery bypass grafting: Are traditional risk scores accurate?
- Author
-
Goncharov M, Mejia OAV, Arthur CPS, Orlandi BMM, Sousa A, Oliveira MAP, Atik FA, Segalote RC, Tiveron MG, de Barros E Silva PGM, Nakazone MA, Lisboa LAF, Dallan LAO, Zheng Z, Hu S, and Jatene FB
- Subjects
- Aged, Area Under Curve, Brazil epidemiology, China epidemiology, Coronary Artery Disease epidemiology, Cross-Sectional Studies, Databases, Factual, Female, Humans, Male, Middle Aged, Prospective Studies, ROC Curve, Risk Assessment, Risk Factors, Treatment Outcome, Coronary Artery Bypass adverse effects, Coronary Artery Disease mortality, Coronary Artery Disease surgery, Hospital Mortality, Models, Statistical
- Abstract
Background: The performance of traditional scores is significantly limited to predict mortality in high-risk cardiac surgery. The aim of this study was to compare the performance of STS, ESII and HiriSCORE models in predicting mortality in high-risk patients undergoing CABG., Methods: Cross-sectional analysis in the international prospective database of high-risk patients: HiriSCORE project. We evaluated 248 patients with STS or ESII (5-10%) undergoing CABG in 8 hospitals in Brazil and China. The main outcome was mortality, defined as all deaths occurred during the hospitalization in which the operation was performed, even after 30 days. Five variables were selected as predictors of mortality in this cohort of patients. The model's performance was evaluated through the calibration-in-the-large and the receiver operating curve (ROC) tests., Results: The mean age was 69.90±9.45, with 52.02% being female, 25% of the patients were on New York Heart Association (NYHA) class IV and 49.6% had Canadian Cardiovascular Society (CCS) class 4 angina, and 85.5% had urgency or emergency status. The mortality observed in the sample was 13.31%. The HiriSCORE model showed better calibration (15.0%) compared to ESII (6.6%) and the STS model (2.0%). In the ROC curve, the HiriSCORE model showed better accuracy (ROC = 0.74) than the traditional models STS (ROC = 0.67) and ESII (ROC = 0.50)., Conclusion: Traditional models were inadequate to predict mortality of high-risk patients undergoing CABG. However, the HiriSCORE model was simple and accurate to predict mortality in high-risk patients., Competing Interests: The authors have no conflict of interest to declare in relation to this work.
- Published
- 2021
- Full Text
- View/download PDF
19. Increased number of ventricular septal rupture cases after acute myocardial infarction in 2020.
- Author
-
Dallan LRP, Dallan LAO, Lisboa LAF, Mejia OAV, Veronese ET, Camilo JPM, Nascimento PCM, and Jatene FB
- Subjects
- Humans, Intra-Aortic Balloon Pumping, Retrospective Studies, Shock, Cardiogenic etiology, Myocardial Infarction complications, Ventricular Septal Rupture epidemiology, Ventricular Septal Rupture etiology, Ventricular Septal Rupture surgery
- Abstract
Introduction: Ventricular septal rupture (VSR) is a serious mechanical complication after acute coronary syndrome and is related to high mortality. Even with advances in the management of acute myocardial infarction (AMI) such as reperfusion therapies, complication rates are still high. During quarantine, patients presenting mechanical complications after AMI have increased in our institution., Methods: From a retrospective database analysis in our institution between the years 2004 and 2020, we identified 37 cases of VSR after AMI. Four chronic cases were excluded from our analysis. The primary endpoint was to identify baseline characteristics that increased 30-day mortality., Results: Among 33 acute cases of VSR, 24 cases were submitted to surgery. The 30-day mortality of the operated patients was 45.8%. From 2004 to 2019 our average number of operations of VSR was 1.9 cases/year with an increase to 4 cases/year in 2020. Diabetes mellitus, age, cardiogenic shock, and use of intra-aortic balloon pump were associated with significantly increased mortality using logistic regression., Conclusion: We reported an increased number of mechanical complication cases from April to September 2020, compared to our historical records. Despite therapeutic advances, mortality rates remain high. Although the number of cases is small to conclude that the pandemic was responsible for this augmentation, we believe that it is related to the decreased number of patients seeking medical assistance., (© 2021 Wiley Periodicals LLC.)
- Published
- 2021
- Full Text
- View/download PDF
20. Brazilian Society of Cardiology Guidelines on Unstable Angina and Acute Myocardial Infarction without ST-Segment Elevation - 2021.
- Author
-
Nicolau JC, Feitosa Filho GS, Petriz JL, Furtado RHM, Précoma DB, Lemke W, Lopes RD, Timerman A, Marin Neto JA, Bezerra Neto L, Gomes BFO, Santos ECL, Piegas LS, Soeiro AM, Negri AJA, Franci A, Markman Filho B, Baccaro BM, Montenegro CEL, Rochitte CE, Barbosa CJDG, Virgens CMBD, Stefanini E, Manenti ERF, Lima FG, Monteiro Júnior FDC, Correa Filho H, Pena HPM, Pinto IMF, Falcão JLAA, Sena JP, Peixoto JM, Souza JA, Silva LSD, Maia LN, Ohe LN, Baracioli LM, Dallan LAO, Dallan LAP, Mattos LAPE, Bodanese LC, Ritt LEF, Canesin MF, Rivas MBDS, Franken M, Magalhães MJG, Oliveira Júnior MT, Filgueiras Filho NM, Dutra OP, Coelho OR, Leães PE, Rossi PRF, Soares PR, Lemos Neto PA, Farsky PS, Cavalcanti RRC, Alves RJ, Kalil RAK, Esporcatte R, Marino RL, Giraldez RRCV, Meneghelo RS, Lima RSL, Ramos RF, Falcão SNDRS, Dalçóquio TF, Lemke VMG, Chalela WA, and Mathias Júnior W
- Subjects
- Angina, Unstable diagnosis, Angina, Unstable therapy, Brazil, Electrocardiography, Humans, Cardiology, Myocardial Infarction therapy
- Published
- 2021
- Full Text
- View/download PDF
21. The use of internal mammary vein in coronary artery surgery.
- Author
-
Dallan LAO, Dallan LRP, Neves Filho A, and Jatene FB
- Subjects
- Aged, Coronary Angiography, Humans, Radial Artery, Saphenous Vein, Vascular Patency, Coronary Artery Bypass, Mammary Arteries
- Abstract
Arterial revascularization, and in particular, left internal mammary artery (LIMA), has shown to improve survival of patients with coronary artery disease. Complete revascularization often requires the use of other grafts and saphenous vein graft is still the most common conduit used. Several other types of grafts have been utilized during revascularization, including the radial artery and gastroepiploic artery. It is recognized that its venous structure can change when submitted to long-term blood pressure regimen. We, herein, report left internal mammary vein (LIMV) utilized as a novel conduit for coronary artery revascularization, that was patent after 6 years. LIMV is an easy graft to harvest if the LIMA is dissected as a pedicle. The long-term patency of LIMV is unknown, but its usage could be suggested for elderly patients with peripheral vascular disease, when long graft patency is not required., (© 2021 Wiley Periodicals LLC.)
- Published
- 2021
- Full Text
- View/download PDF
22. Platelet Reactivity in Patients With Acute Coronary Syndromes Awaiting Surgical Revascularization.
- Author
-
Nakashima CAK, Dallan LAO, Lisboa LAF, Jatene FB, Hajjar LA, Soeiro AM, Furtado RHM, Dalçoquio TF, Baracioli LM, Lima FG, Giraldez RRCV, Silva BA, Costa MSS, Strunz CMC, Dallan LRP, Barbosa CJDG, Britto FAB, Farkouh ME, Gurbel PA, and Nicolau JC
- Subjects
- Acute Coronary Syndrome economics, Acute Coronary Syndrome surgery, Aged, Aspirin administration & dosage, Aspirin adverse effects, Blood Transfusion statistics & numerical data, Female, Hospital Costs statistics & numerical data, Humans, Male, Middle Aged, Platelet Aggregation Inhibitors administration & dosage, Platelet Aggregation Inhibitors adverse effects, Postoperative Hemorrhage chemically induced, Postoperative Hemorrhage prevention & control, Preoperative Care instrumentation, Purinergic P2Y Receptor Antagonists adverse effects, Acute Coronary Syndrome drug therapy, Blood Coagulation Tests instrumentation, Coronary Artery Bypass statistics & numerical data, Purinergic P2Y Receptor Antagonists administration & dosage, Time-to-Treatment statistics & numerical data
- Abstract
Background: Dual antiplatelet therapy is recommended for patients with acute coronary syndromes (ACS). Approximately 10% to 15% of these patients will undergo coronary artery bypass graft (CABG) surgery for index events, and current guidelines recommend stopping clopidogrel at least 5 days before CABG. This waiting time has clinical and economic implications., Objectives: This study aimed to evaluate if a platelet reactivity-based strategy is noninferior to standard of care for 24-h post-CABG bleeding., Methods: In this randomized, open label noninferiority trial, 190 patients admitted with ACS with indications for CABG and on aspirin and P2Y
12 receptor inhibitors, were assigned to either control group, P2Y12 receptor inhibitor withdrawn 5 to 7 days before CABG, or intervention group, daily measurements of platelet reactivity by Multiplate analyzer (Roche Diagnostics GmbH, Vienna, Austria) with CABG planned the next working day after platelet reactivity normalization (pre-defined as ≥46 aggregation units)., Results: Within the first 24 h of CABG, the median chest tube drainage was 350 ml (interquartile range [IQR]: 250 to 475 ml) and 350 ml (IQR: 255 to 500 ml) in the intervention and control groups, respectively (p for noninferiority <0.001). The median waiting period between the decision to undergo CABG and the procedure was 112 h (IQR: 66 to 142 h) and 136 h (IQR: 112 to 161 h) (p < 0.001), respectively. In the intention-to-treat analysis, a 6.4% decrease in the median in-hospital expenses was observed in the intervention group (p = 0.014), with 11.2% decrease in the analysis per protocol (p = 0.003)., Conclusions: A strategy based on platelet reactivity-guided is noninferior to the standard of care in patients with ACS awaiting CABG regarding peri-operative bleeding, significantly shortens the waiting time to CABG, and decreases hospital expenses. (Evaluation of Platelet Aggregability in the Release of CABG in Patients With ACS With DAPT; NCT02516267)., Competing Interests: Funding Support and Author Disclosures This study was financed in part by the Coordination for the Improvement of Higher Education Personnel-Brazil (CAPES) – Finance Code 001. Dr. Furtado has received grants and personal fees from AstraZeneca; personal fees from Servier; and grants from EMS, Pfizer, Novo Nordisk, DalCor, Novartis, and Janssen, all outside the submitted work. Dr. Baracioli has received personal fees from Sandoz. Dr. Barbosa has received personal fees from Bayer, Daiichi-Sankyo, and Servier. Dr. Britto has received research grants from Novo Nordisk, DalCor, AstraZeneca, and Novartis. Dr. Farkouh has received research grants from Amgen, Novartis, and Novo Nordisk. Dr. Gurbel has received consultant and/or receives honoraria from Bayer, Merck, Janssen, Medicure, and USWorld Meds; has received grants from the National Institutes of Health, Janssen, Merck, Bayer, Haemonetics, Instrumentation Labs, and Amgen; holds stock or stock options in Merck, Medtronic, and Pfizer; and holds patents in the area of personalized antiplatelet therapy and interventional cardiology. Dr. Nicolau has received personal fees from AMGEN; has received grants from AstraZeneca, Bristol Myers Squibb, CLS Behring, Dalcor, Janssen, NovoNordisk, and Vifor; has received grants and personal fees from Bayer, Novartis, and Sanofi; and has received personal fees from Daiichi-Sankyo and Servier. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose., (Copyright © 2021 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.)- Published
- 2021
- Full Text
- View/download PDF
23. Bentall-de Bono procedure for acute aortic dissection.
- Author
-
Dallan LRP, Dallan LAO, Duncan Santiago JA, Ribeiro Dias R, Manuel de Almeida Brandao C, and Jatene FB
- Subjects
- Humans, Male, Middle Aged, Replantation, Aortic Dissection surgery, Aorta surgery, Aortic Aneurysm, Thoracic surgery, Vascular Surgical Procedures methods
- Abstract
We present a patient with an acute type A aortic dissection that involves the aortic root. The high mortality of patients with this condition is often associated with operations performed by surgeons with minimal experience dealing with aortic diseases. Therefore, less-experienced surgeons often opt for less complicated techniques like supracoronary ascending aortic replacement. However, according to the latest guidelines for the management of aortic diseases, the aortic root should be replaced when it is compromised by the dissection. The Bentall-de Bono technique treats the aortic root and demands less experience than valve-sparing aortic surgery., (© The Author 2021. Published by MMCTS on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
24. Coronary Artery Bypass Graft During the COVID-19 Pandemic.
- Author
-
Silveira LMVD, Guerreiro GP, Lisboa LAF, Mejía OAV, Dallan LRP, Dallan LAO, and Jatene FB
- Subjects
- Brazil, Humans, Pandemics, COVID-19 complications, Coronary Artery Bypass mortality
- Abstract
Since the beginning of the coronavirus disease (COVID-19) pandemic, in March 2020, the number of people infected with COVID-19 worldwide increases continuously. Brazil is being followed with great concern in the international media, as it can, very soon, be the epicenter of the pandemic. Initial surgical data suggest that patients who acquire COVID-19 in the perioperative period are prone to a higher morbidity and mortality, however, evidence in cardiac surgery is still scarce. This article aims to aggregate to the growing evidence suggesting that perioperative infection with severe acute respiratory syndrome coronavirus 2 contributes to a more morbid evolution of the case.
- Published
- 2020
- Full Text
- View/download PDF
25. Current Impact of Cardiopulmonary Bypass in Coronary Artery Bypass Grafting in São Paulo State.
- Author
-
Borgomoni GB, Mejia OAV, Orlandi BMM, Goncharov M, Lisboa LAF, Conte PH, Oliveira MAP, Fiorelli AI, Petrucci Junior O, Tiveron MG, Dallan LAO, and Jatene FB
- Subjects
- Humans, Male, Myocardial Revascularization, Reoperation, Treatment Outcome, Cardiopulmonary Bypass, Coronary Artery Bypass
- Abstract
Background: Previous results on the use of cardiopulmonary bypass (CPB) have generated difficulties in choosing the best treatment for each patient undergoing myocardial revascularization surgery (CABG) in the current context., Objective: Evaluate the current impact of CPB in CABG in São Paulo State., Methods: A total of 2905 patients who underwent CABG were consecutively analyzed in 11 São Paulo State centers belonging to the São Paulo Registry of Cardiovascular Surgery (REPLICCAR) I. Perioperative and follow-up data were included online by trained specialists in each hospital. Associations of the perioperative variables with the type of procedure and with the outcomes were analyzed. The study outcomes were morbidity and operative mortality. The expected mortality was calculated using EuroSCORE II (ESII). The values of p <5% were considered significant., Results: There were no significant differences concerning the patients' age between the groups (p=0.081). 72.9% of the patients were males. Of the patients, 542 underwent surgery without CPB (18.7%). Of the preoperative characteristics, patients with previous myocardial infarction (p=0.005) and ventricular dysfunction (p=0.031) underwent surgery with CPB. However, emergency or New York Heart Association (NYHA) class IV patients underwent surgery without CPB (p<0.001). The ESII value was similar in both groups (p=0.427). In CABG without CPB, the radial graft was preferred (p<0.001), and in CABG with CPB the right mammary artery was the preferred one (p<0.001). In the postoperative period, CPB use was associated with reoperation for bleeding (p=0.012)., Conclusion: Currently in the REPLICCAR, reoperation for bleeding was the only outcome associated with the use of CPB in CABG. (Arq Bras Cardiol. 2020; 115(4):595-601).
- Published
- 2020
- Full Text
- View/download PDF
26. Perspectives of the Young Cardiovascular Surgeon.
- Author
-
Dallan LAO and Jatene FB
- Subjects
- Attitude of Health Personnel, Humans, Cardiovascular Diseases surgery, Surgeons
- Published
- 2020
- Full Text
- View/download PDF
27. REPLICCAR II Study: Data quality audit in the Paulista Cardiovascular Surgery Registry.
- Author
-
Orlandi BMM, Mejia OAV, Borgomoni GB, Goncharov M, Rocha KN, Bassolli L, Melo de Barros E Silva PG, Nakazone MA, Sousa A, Campagnucci VP, de Sousa Vilarinho KA, Katz M, Tiveron MG, Arrais Dos Santos M, Lisboa LAF, Dallan LAO, and Jatene FB
- Subjects
- Brazil, Cardiovascular Surgical Procedures, Data Accuracy, Humans, Registries, Databases, Factual
- Abstract
The quality of data in electronic healthcare databases is a critical component when used for research and health practice. The aim of the present study was to assess the data quality in the Paulista Cardiovascular Surgery Registry II (REPLICCAR II) using two different audit methods, direct and indirect. The REPLICCAR II database contains data from 9 hospitals in São Paulo State with over 700 variables for 2229 surgical patients. The data collection was performed in REDCap platform using trained data managers to abstract information. We directly audited a random sample (n = 107) of the data collected after 6 months and indirectly audited the entire sample after 1 year of data collection. The indirect audit was performed using the data management tools in REDCap platform. We computed a modified Aggregate Data Quality Score (ADQ) previously reported by Salati et al. (2015). The agreement between data elements was good for categorical data (Cohen κ = 0.7, 95%CI = 0.59-0.83). For continuous data, the intraclass coefficient (ICC) for only 2 out of 15 continuous variables had an ICC < 0.9. In the indirect audit, 77% of the selected variables (n = 23) had a good ADQ score for completeness and accuracy. Data entry in the REPLICCAR II database proved to be satisfactory and showed competence and reliable data for research in cardiovascular surgery in Brazil., Competing Interests: We know of no conflicts of interest associated with this publication.
- Published
- 2020
- Full Text
- View/download PDF
28. Geometric reconstruction of a left ventricular aneurysm with coronary artery bypass graft.
- Author
-
Dallan LRP, Dallan LAO, Lisboa LAF, Mejia OAV, Dallan LAP, and Jatene FB
- Subjects
- Aged, Humans, Male, Saphenous Vein transplantation, Coronary Artery Bypass, Heart Aneurysm surgery, Heart Ventricles surgery
- Abstract
Left ventricular aneurysm is a late mechanical complication of untreated acute myocardial infarction. It has become relatively rare since the development of percutaneous cardiac intervention. Most aneurysms are located at the anterior ventricular wall, and are caused by total occlusion of the left anterior descending artery. Usually, the anterior and apical walls initially become akinetic; this can sometimes evolve into dyskinesia. Thrombus formation is a common finding, since the apical contractility is impaired. This tutorial illustrates the challenging technical aspects of a large thrombus removal, along with the geometric reconstruction of the left ventricular aneurysm and coronary bypass surgery., (© The Author 2020. Published by MMCTS on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
29. Hypotheses, rationale, design, and methods for prognostic evaluation of a randomized comparison between patients with coronary artery disease associated with ischemic cardiomyopathy who undergo medical or surgical treatment: MASS-VI (HF).
- Author
-
Rezende PC, Hueb W, Bocchi EA, Farkouh M, Junior CVS, Lima EG, Silva EER, Dallan LAO, Gaiotto FA, Garzillo CL, Rochitte CE, Nomura CH, Scudeler TL, Soares PR, Jatene FB, Ramires JAF, and Filho RK
- Subjects
- Adrenergic beta-Antagonists therapeutic use, Angiotensin Receptor Antagonists therapeutic use, Angiotensin-Converting Enzyme Inhibitors therapeutic use, Coronary Artery Disease drug therapy, Coronary Artery Disease mortality, Cost-Benefit Analysis, Diuretics therapeutic use, Follow-Up Studies, Heart Failure etiology, Heart Failure surgery, Humans, Myocardial Ischemia drug therapy, Myocardial Ischemia mortality, Prognosis, Prospective Studies, Randomized Controlled Trials as Topic, Stroke Volume, Treatment Outcome, Ventricular Dysfunction, Left drug therapy, Ventricular Dysfunction, Left mortality, Coronary Artery Bypass methods, Coronary Artery Disease complications, Coronary Artery Disease surgery, Myocardial Ischemia complications, Myocardial Ischemia surgery, Ventricular Dysfunction, Left complications, Ventricular Dysfunction, Left surgery
- Abstract
Background: Ischemic cardiomyopathy and severe left ventricular dysfunction are well established to represent the main determinants of poor survival and premature death compared with preserved ventricular function. However, the role of myocardial revascularization as a therapeutic alternative is not known to improve the long-term prognosis in this group of patients. This study will investigate whether myocardial revascularization contributes to a better prognosis for patients compared with those treated with drugs alone and followed over the long term., Methods: The study will include 600 patients with coronary artery disease associated with ischemic cardiomyopathy. The surgical or drug therapy option will be randomized, and the events considered for analysis will be all-cause mortality, nonfatal infarction, unstable angina requiring additional revascularization, and stroke. The events will be analyzed according to the intent-to-treat principle. Patients with multivessel coronary disease and left ventricular ejection fraction measurements of less than 35% will be included. In addition, myocardial ischemia will be documented by myocardial scintigraphy. Markers of myocardial necrosis will be checked at admission and after the procedure., Discussion: The role of myocardial revascularization (CABG) in the treatment of patients with coronary artery disease and heart failure is not clearly established. The surgical option of revascularizing the myocardium is a procedure designed to reduce the load of myocardial hibernation in patients with heart failure caused by coronary artery disease. On the other hand, the assessment of myocardial viability is frequently used to identify patients with left ventricular ischemic dysfunction in which CABG may add survival benefit. However, the effectiveness of this option is uncertain. The great difficulty in establishing the efficacy of surgical intervention is based on the understanding of viability without ischemia. Thus, this study will include only patients with viable and truly ischemic myocardium to correct this anomaly., Trial Registration: Evaluation of a randomized comparison between patients with coronary artery disease associated with ischemic cardiomyopathy submitted to medical or surgical treatment: MASS-VI (HF), ISRCTN77449548, Oct 10th, 2019 (retrospectively registered).
- Published
- 2020
- Full Text
- View/download PDF
30. Analysis of >100,000 Cardiovascular Surgeries Performed at the Heart Institute and a New Era of Outcomes.
- Author
-
Mejia OAV, Lisboa LAF, Caneo LF, Arita ET, Brandão CMA, Dias RR, Costa R, Jatene MB, Pomerantzeff PMA, Dallan LAO, and Jatene FB
- Subjects
- Hospital Mortality, Humans, Incidence, Treatment Outcome, Vascular Surgical Procedures, Cardiac Surgical Procedures, Heart Defects, Congenital
- Abstract
Background: The current challenge of cardiovascular surgery (CVS) is to improve the outcomes in increasingly severe patients. In this respect, continuous quality improvement (CQI) programs have had an impact on outcomes., Objective: To assess the evolution of the incidence and mortality due to CVS, as well as the current outcomes of the Hospital das Clínicas Heart Institute of the University of São Paulo Medical School (InCor-HCFMUSP)., Methods: An outcome analysis of CVSs performed at the InCor, between January 1984 and June 2019. We observed the surgical volume and mortality rates in 5 time periods: 1st (1984-1989), 2nd (1990-1999), 3rd (2000-2007), 4th (2008-2015) and 5th (2016-2019). The CQI program was implemented between 2015 and 2016. The analysis included the total number of surgeries and the evolution of the most frequent procedures., Results: A total of 105,599 CCVs were performed, with an annual mean of 2,964 procedures and mortality of 5,63%. When comparing the 4th and the 5th periods, the average global volume of surgeries was increased from 2,943 to 3,139 (p = 0.368), bypass graft (CABG), from 638 to 597 (p = 0.214), heart valve surgery, from 372 to 465 (p = 0.201), and congenital heart disease surgery, from 530 to 615 (p = 0.125). The average global mortality went from 7.8% to 5% (p < 0.0001); in CABG surgery, from 5.8% to 3.1% (p < 0.0001); in heart valve surgery, from 14% to 7.5% (p < 0.0001) and in congenital heart disease surgery, from 12.1% to 9.6% (p < 0.0001)., Conclusion: In spite of a recent trend towards increased surgical volume, there was a significant decrease in operative mortality in the groups studied. After the implementation of the CQI program, the mortality rates were closer to international standards.
- Published
- 2020
- Full Text
- View/download PDF
31. Does prior coronary angioplasty affect outcomes of surgical coronary revascularization? Insights from the STICH trial.
- Author
-
Nicolau JC, Stevens SR, Al-Khalidi HR, Jatene FB, Furtado RHM, Dallan LAO, Lisboa LAF, Desvigne-Nickens P, Haddad H, Jolicoeur EM, Petrie MC, Doenst T, Michler RE, Ohman EM, Maddury J, Ali I, Deja MA, Rouleau JL, Velazquez EJ, and Hill JA
- Subjects
- Aged, Angioplasty mortality, Coronary Artery Bypass mortality, Coronary Artery Disease diagnostic imaging, Coronary Artery Disease mortality, Female, Follow-Up Studies, Humans, Male, Middle Aged, Mortality trends, Myocardial Revascularization mortality, Percutaneous Coronary Intervention mortality, Prospective Studies, Stroke Volume physiology, Ventricular Dysfunction, Left diagnostic imaging, Ventricular Dysfunction, Left mortality, Angioplasty trends, Coronary Artery Bypass trends, Coronary Artery Disease surgery, Myocardial Revascularization trends, Percutaneous Coronary Intervention trends, Ventricular Dysfunction, Left surgery
- Abstract
Background: The STICH trial showed superiority of coronary artery bypass plus medical treatment (CABG) over medical treatment alone (MED) in patients with left ventricular ejection fraction (LVEF) ≤35%. In previous publications, percutaneous coronary intervention (PCI) prior to CABG was associated with worse prognosis., Objectives: The main purpose of this study was to analyse if prior PCI influenced outcomes in STICH., Methods and Results: Patients in the STICH trial (n = 1212), followed for a median time of 9.8 years, were included in the present analyses. In the total population, 156 had a prior PCI (74 and 82, respectively, in the MED and CABG groups). In those with vs. without prior PCI, the adjusted hazard-ratios (aHRs) were 0.92 (95% CI = 0.74-1.15) for all-cause mortality, 0.85 (95% CI = 0.64-1.11) for CV mortality, and 1.43 (95% CI = 1.15-1.77) for CV hospitalization. In the group randomized to CABG without prior PCI, the aHRs were 0.82 (95% CI = 0.70-0.95) for all-cause mortality, 0.75 (95% CI = 0.62-0.90) for CV mortality and 0.67 (95% CI = 0.56-0.80) for CV hospitalization. In the group randomized to CABG with prior PCI, the aHRs were 0.76 (95% CI = 0.50-1.15) for all-cause mortality, 0.81 (95% CI = 0.49-1.36) for CV mortality and 0.61 (95% CI = 0.41-0.90) for CV hospitalization. There was no evidence of interaction between randomized treatment and prior PCI for any endpoint (all adjusted p > 0.05)., Conclusion: In the STICH trial, prior PCI did not affect the outcomes of patients whether they were treated medically or surgically, and the superiority of CABG over MED remained unchanged regardless of prior PCI., Clinical Trial Registration: Clinicaltrials.gov; Identifier: NCT00023595., (Copyright © 2019 Elsevier B.V. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
32. Comment on the study Coronary Artery Bypass Surgery in Brazil: Analysis of the National Reality Through the Bypass Registry that was presented at the 46 th Congress of the Brazilian Society of Cardiovascular Surgery, Nova Lima, BH, Brazil, April 5 and 6, 2019.
- Author
-
Dallan LAO
- Subjects
- Brazil, Registries, Coronary Artery Bypass
- Published
- 2019
- Full Text
- View/download PDF
33. Activation of Interleukin-1 Beta in Arterialized Vein Grafts and the Influence of the -511C/T IL-1β Gene Polymorphism.
- Author
-
Miyakawa AA, Borin TF, Campos LCG, Girão-Silva T, Ribeiro-Silva JC, Dallan LAO, and Krieger JE
- Abstract
The interleukin-1 family is associated with innate immunity and inflammation. The latter has been linked to the genesis of cardiovascular diseases. We, therefore, investigated whether interleukin-1 beta (IL-1β) is activated during arterialization of vein grafts. First, we examined the activation of IL-1β using the rat arterialized jugular vein serially sampled for up to 90 days. IL-1β expression increased 18 times on day 1 in the arterialized rat jugular vein and remained five times above nonarterialized vein levels for up to 90 days. Similarly, IL-1β expression increased early (1-5 days) in human vein graft autopsy samples compared with late phases (1-4 years). Activation was also detected in ex vivo arterialized human saphenous veins. Upon stratification of the results, we uncovered a T allele promoter attenuating effect in IL-1β activation in response to hemodynamic stress. Altogether, the results show that IL-1β is activated during arterialization of vein grafts in rats and humans, and this response is modulated by -511C/T IL-1β gene polymorphism. It is tempting to speculate that the activation of IL-1β, and consequently local inflammation, modulates early vascular remodeling and that the gene polymorphism may be useful in predicting outcomes or assisting in interventions.
- Published
- 2019
- Full Text
- View/download PDF
34. Perioperative Management of the Diabetic Patient Referred to Cardiac Surgery.
- Author
-
Arthur CPS, Mejía OAV, Lapenna GA, Brandão CMA, Lisboa LAF, Dias RR, Dallan LAO, Pomerantzeff PMA, and Jatene FB
- Subjects
- Clinical Protocols, Evidence-Based Medicine, Humans, Cardiac Surgical Procedures, Diabetes Mellitus drug therapy, Hyperglycemia drug therapy, Hypoglycemic Agents administration & dosage, Perioperative Care, Postoperative Complications prevention & control
- Abstract
Currently there is a progressive increase in the prevalence of diabetes in a referred for cardiovascular surgery. Benefits of glycemic management (< 180 mg/dL) in diabetic patients compared to patients without diabetes in perioperative cardiac surgery. The purpose of this study is to present recommendations based on international evidence and adapted to our clinical practice for the perioperative management of hyperglycemia in adult patients with and without diabetes undergoing cardiovascular surgery. This update is based on the latest current literature derived from articles and guidelines regarding perioperative management of diabetic patients to cardiovascular surgery.
- Published
- 2018
- Full Text
- View/download PDF
35. Coronary Artery Bypass Surgery in Diffuse Advanced Coronary Artery Disease: 1-Year Clinical and Angiographic Results.
- Author
-
Dourado LOC, Bittencourt MS, Pereira AC, Poppi NT, Dallan LAO, Krieger JE, Cesar LAM, and Gowdak LHW
- Subjects
- Aged, Brazil, Coronary Artery Disease physiopathology, Coronary Vessels physiopathology, Female, Graft Occlusion, Vascular diagnostic imaging, Graft Occlusion, Vascular etiology, Graft Occlusion, Vascular physiopathology, Hematopoietic Stem Cell Transplantation, Humans, Male, Middle Aged, Predictive Value of Tests, Risk Factors, Severity of Illness Index, Time Factors, Treatment Outcome, Vascular Patency, Coronary Angiography, Coronary Artery Bypass adverse effects, Coronary Artery Disease diagnostic imaging, Coronary Artery Disease surgery, Coronary Vessels diagnostic imaging, Coronary Vessels surgery
- Abstract
Background: Proper treatment of patients with diffuse, severe coronary artery disease (CAD) is a challenge due to its complexity. Thus, data on the outcomes after coronary artery bypass graft (CABG) in this population is scarce. In this study, we aimed to determine the impact of CABG on the clinical and functional status, as well as graft patency in those individuals., Methods: Patients with severe and diffuse CAD who underwent incomplete CABG due to complex anatomy or extensive distal coronary involvement were evaluated preoperatively and 1 year after surgery. Postoperative coronary angiography was performed to evaluate graft patency. Graft occlusion was defined as the complete absence of opacification of the target vessel. Stratified analysis of graft occlusion was performed by graft type and territories, defined as left anterior descending artery (LAD), the left circumflex branch, and the right coronary artery territories; the latter two, grouped, were further classified as non-LAD territory., Results: A total of 57 patients were included, in whom 131 grafts were placed. There was a significant improvement in Canadian Cardiovascular Society angina symptom severity ( Z = -6.1; p < 0.001) and maximum oxygen uptake ( p < 0.001), with a corresponding decrease in the use of long-acting nitrates ( p < 0.001). The overall graft occlusion rate was 19.1%, with no significant difference between LAD and non-LAD territories ( p = 0.08). However, a significantly lower occlusion rate was noted for the internal mammary artery (IMA) grafts when compared with saphenous vein grafts ( p = 0.01), though this difference was only significant in the LAD territory ( p = 0.04). Overall, the use of venous graft was the only predictor occlusion at 1 year (odds ratio: 4.03; p = 0.016)., Conclusion: In patients with diffuse CAD, incomplete CABG surgery resulted in a significant clinical improvement, with acceptable graft occlusion rates at 1 year, particularly for IMA grafts to the LAD territory., Competing Interests: None., (Georg Thieme Verlag KG Stuttgart · New York.)
- Published
- 2018
- Full Text
- View/download PDF
36. Predictive performance of six mortality risk scores and the development of a novel model in a prospective cohort of patients undergoing valve surgery secondary to rheumatic fever.
- Author
-
Mejia OAV, Antunes MJ, Goncharov M, Dallan LRP, Veronese E, Lapenna GA, Lisboa LAF, Dallan LAO, Brandão CMA, Zubelli J, Tarasoutchi F, Pomerantzeff PMA, and Jatene FB
- Subjects
- Aged, Female, Heart Valve Diseases physiopathology, Heart Valve Diseases surgery, Hospital Mortality, Humans, Male, Middle Aged, Rheumatic Fever physiopathology, Rheumatic Fever surgery, Rheumatic Heart Disease physiopathology, Rheumatic Heart Disease surgery, Risk Assessment, Risk Factors, Cardiac Surgical Procedures adverse effects, Heart Valve Diseases mortality, Rheumatic Fever mortality, Rheumatic Heart Disease mortality
- Abstract
Background: Mortality prediction after cardiac procedures is an essential tool in clinical decision making. Although rheumatic cardiac disease remains a major cause of heart surgery in the world no previous study validated risk scores in a sample exclusively with this condition., Objectives: Develop a novel predictive model focused on mortality prediction among patients undergoing cardiac surgery secondary to rheumatic valve conditions., Methods: We conducted prospective consecutive all-comers patients with rheumatic heart disease (RHD) referred for surgical treatment of valve disease between May 2010 and July of 2015. Risk scores for hospital mortality were calculated using the 2000 Bernstein-Parsonnet, EuroSCORE II, InsCor, AmblerSCORE, GuaragnaSCORE, and the New York SCORE. In addition, we developed the rheumatic heart valve surgery score (RheSCORE)., Results: A total of 2,919 RHD patients underwent heart valve surgery. After evaluating 13 different models, the top performing areas under the curve were achieved using Random Forest (0.982) and Neural Network (0.952). Most influential predictors across all models included left atrium size, high creatinine values, a tricuspid procedure, reoperation and pulmonary hypertension. Areas under the curve for previously developed scores were all below the performance for the RheSCORE model: 2000 Bernstein-Parsonnet (0.876), EuroSCORE II (0.857), InsCor (0.835), Ambler (0.831), Guaragna (0.816) and the New York score (0.834). A web application is presented where researchers and providers can calculate predicted mortality based on the RheSCORE., Conclusions: The RheSCORE model outperformed pre-existing scores in a sample of patients with rheumatic cardiac disease., Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2018
- Full Text
- View/download PDF
37. Do We Need to Personalize Renal Function Assessment in the Stratification of Patients Undergoing Cardiac Surgery?
- Author
-
Arthur CPS, Mejia OAV, Osternack D, Nakazone MA, Goncharov M, Lisboa LAF, Dallan LAO, Pomerantzeff PMA, and Jatene FB
- Subjects
- Aged, Calibration, Cross-Sectional Studies, Female, Humans, Logistic Models, Male, Middle Aged, Morbidity, Prospective Studies, Reference Standards, Reference Values, Reproducibility of Results, Risk Factors, Sensitivity and Specificity, Cardiac Surgical Procedures mortality, Creatinine blood, Glomerular Filtration Rate physiology, Renal Insufficiency blood, Renal Insufficiency mortality, Risk Assessment methods
- Abstract
Background: Renal dysfunction is an independent predictor of morbidity and mortality in cardiac surgery. For a better assessment of renal function, calculation of creatinine clearance (CC) may be necessary., Objective: To objectively evaluate whether CC is a better risk predictor than serum creatinine (SC) in patients undergoing cardiac surgery., Methods: Analysis of 3,285 patients registered in a prospective, consecutive and mandatory manner in the Sao Paulo Registry of Cardiovascular Surgery (REPLICCAR) between November 2013 and January 2015. Values of SC, CC (Cockcroft-Gault) and EuroSCORE II were obtained. Association analysis of SC and CC with morbidity and mortality was performed by calibration and discrimination tests. Independent multivariate models with SC and CC were generated by multiple logistic regression to predict morbidity and mortality following cardiac surgery., Results: Despite the association between SC and mortality, it did not calibrate properly the risk groups. There was an association between CC and mortality with good calibration of risk groups. In mortality risk prediction, SC was uncalibrated with values > 1.35 mg /dL (p < 0.001). The ROC curve showed that CC is better than SC in predicting both morbidity and mortality risk. In the multivariate model without CC, SC was the only predictor of morbidity, whereas in the model without SC, CC was not only a mortality predictor, but also the only morbidity predictor., Conclusion: Compared with SC, CC is a better parameter of renal function in risk stratification of patients undergoing cardiac surgery.
- Published
- 2017
- Full Text
- View/download PDF
38. Off-pump versus On-pump Coronary Artery Bypass Grafting in Frail Patients: Study Protocol for the FRAGILE Multicenter Randomized Controlled Trial.
- Author
-
Mejía OAV, Sá MPBO, Deininger MO, Dallan LRP, Segalote RC, Oliveira MAP, Atik FA, Santos MAD, Silva PGMBE, Milani RM, Hueb AC, Monteiro R, Lima RC, Lisboa LAF, Dallan LAO, Puskas J, and Jatene FB
- Subjects
- Aged, Coronary Artery Bypass adverse effects, Coronary Artery Bypass mortality, Coronary Artery Bypass, Off-Pump adverse effects, Coronary Artery Bypass, Off-Pump mortality, Follow-Up Studies, Frail Elderly, Humans, Risk Assessment, Treatment Outcome, Coronary Artery Bypass methods, Coronary Artery Bypass, Off-Pump methods
- Abstract
Introduction: Advances in modern medicine have led to people living longer and healthier lives. Frailty is an emerging concept in medicine yet to be explored as a risk factor in cardiac surgery. When it comes to CABG surgery, randomized controlled clinical trials have primarily focused on low-risk (ROOBY, CORONARY), elevated-risk (GOPCABE) or high-risk patients (BBS), but not on frail patients. Therefore, we believe that off-pump CABG could be an important technique in patients with limited functional capacity to respond to surgical stress. In this study, the authors introduce the new national, multicenter, randomized, controlled trial "FRAGILE", to be developed in the main cardiac surgery centers of Brazil, to clarify the potential benefit of off-pump CABG in frail patients., Methods: FRAGILE is a two-arm, parallel-group, multicentre, individually randomized (1:1) controlled trial which will enroll 630 patients with blinded outcome assessment (at 30 days, 6 months, 1 year, 2 years and 3 years), which aims to compare adverse cardiac and cerebrovascular events after off-pump versus on-pump CABG in pre-frail and frail patients. Primary outcomes will be all-cause mortality, acute myocardial infarction, cardiac arrest with successful resuscitation, low cardiac output syndrome/cardiogenic shock, stroke, and coronary reintervention. Secondary outcomes will be major adverse cardiac and cerebrovascular events, operative time, mechanical ventilation time, hyperdynamic shock, new onset of atrial fibrillation, renal replacement therapy, reoperation for bleeding, pneumonia, length of stay in intensive care unit, length of stay in hospital, number of units of blood transfused, graft patency, rate of complete revascularization, neurobehavioral outcomes after cardiac surgery, quality of life after cardiac surgery and costs., Discussion: FRAGILE trial will determine whether off-pump CABG is superior to conventional on-pump CABG in the surgical treatment of pre-frail and frail patients., Trial Registration: ClinicalTrials.gov, ID: NCT02338947. Registered on August 29th 2014; last updated on March 21st 2016.
- Published
- 2017
- Full Text
- View/download PDF
39. Myocardial Inactivation of Thyroid Hormones in Patients with Aortic Stenosis.
- Author
-
Paolino BS, Pomerantzeff PM, Dallan LAO, Gaiotto FA, Preite NZ, Latrônico AC, Nicolau JC, Bianco AC, and Giraldez RRCV
- Subjects
- Aged, Aortic Valve Stenosis pathology, Female, Humans, Male, Middle Aged, Myocardium pathology, Aortic Valve Stenosis metabolism, Myocardium metabolism, Triiodothyronine blood
- Abstract
Objective: The human heart expresses the type 2 deiodinase (D2) that activates thyroxine (T4) to triiodothyronine (T3). At the same time, the inactivating type 3 deiodinase (D3) has been found in a rat model of right ventricular hypertrophy. It is not known whether the human myocardium metabolizes thyroid hormone. This study examined myocardial thyroid hormone metabolism in patients with aortic valve stenosis (AS) undergoing aortic valve replacement and in patients with coronary artery disease (CAD) undergoing coronary artery bypass grafting surgery., Methods: Myocardial thyroid hormone metabolism was assessed by analyzing the difference in serum thyroid hormone levels between the aortic root (incoming blood) and the coronary sinus (outgoing blood) of patients undergoing cardiac surgery. A total of 23 patients with AS and 35 patients with CAD were included. Patients received a pre-surgical echocardiogram, and pre-, during and post-surgical thyroid hormone serum levels were collected in the myocardial and peripheral circulations., Results: Patients with AS exhibited the expected left ventricle (LV) hypertrophy (i.e., 20-30% increase in LV posterior wall and interventricular septum thickness and ∼10% increase in AS in LV diastolic diameter). Immediately before cardiopulmonary bypass, blood flowing through the AS myocardium exhibited a 4.6% reduction in T3 and 6.9% increase in rT3 levels, decreasing the serum T3/rT3 ratio by 9.6%. T4 and thyrotropin serum levels remained similar between the aortic root and coronary sinus. In contrast, no myocardial thyroid hormone metabolism was observed in CAD patients. Notably, the AS myocardium lost the ability to inactivate thyroid hormone after cardiopulmonary bypass, possibly due to myocardial stunning., Conclusions: There is accelerated thyroid hormone inactivation in the AS myocardium, which is likely the result of D3 expression. No evidence to suggest thyroid hormone activation in the myocardium was obtained in the present study.
- Published
- 2017
- Full Text
- View/download PDF
40. β-arrestin is critical for early shear stress-induced Akt/eNOS activation in human vascular endothelial cells.
- Author
-
Carneiro AP, Fonseca-Alaniz MH, Dallan LAO, Miyakawa AA, and Krieger JE
- Subjects
- Caveolin 1 metabolism, Cells, Cultured, Down-Regulation, Humans, Mechanotransduction, Cellular physiology, Phosphorylation, RNA, Small Interfering genetics, Signal Transduction, Stress, Mechanical, beta-Arrestin 1 antagonists & inhibitors, beta-Arrestin 1 genetics, beta-Arrestin 2 antagonists & inhibitors, beta-Arrestin 2 genetics, Endothelial Cells metabolism, Nitric Oxide Synthase Type III metabolism, Proto-Oncogene Proteins c-akt metabolism, beta-Arrestin 1 metabolism, beta-Arrestin 2 metabolism
- Abstract
Recent evidence suggests that β-arrestins, which are involved in G protein-coupled receptors desensitization, may influence mechanotransduction. Here, we observed that nitric oxide (NO) production was abrogated in human saphenous vein endothelial cells (SVECs) transfected with siRNA against β-arrestin 1 and 2 subjected to shear stress (SS, 15 dynes/cm
2 , 10 min). The downregulation of β-arrestins 1/2 in SVECs cells also prevented the SS-induced rise in levels of phosphorylation of Akt and endothelial nitric oxide synthase (eNOS, Serine 1177). Interestingly, immunoprecipitation revealed that β-arrestin interacts with Akt, eNOS and caveolin-1 and these interactions are not influenced by SS. Our data indicate that β-arrestins and Akt/eNOS downstream signaling are required for early SS-induced NO production in SVECs, which is consistent with the idea that β-arrestins and caveolin-1 are part of a pre-assembled complex associated with the cellular mechanotransduction machinery., (Copyright © 2017 Elsevier Inc. All rights reserved.)- Published
- 2017
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.